English
Locally Advanced Head and neck Cancer (LA-HNSCC) represents a significant clinical challenge. The standard of care (SOC) typically involves a combination of surgery, chemotherapy, and radiation therapy. However, there are significant limitations associated with these […]
For patients with unresected Locally Advanced Head & Neck Cancer (LA-SCCHN) who cannot undergo surgical resection, the current standard of care is high-dose cisplatin-based CRT which has shown to improve locoregional control, PFS and OS compared […]
The domain of Non-alcoholic steatohepatitis (NASH) and Obesity treatment is continually evolving, with new discoveries and insights that are reshaping our understanding of how to best combat this liver disease. One of the most talked-about […]
In the realm of Gastrointestinal Endoscopy, as the medical field advances, the integration of state-of-the-art technology is inevitable. Endoscopy has been a mainstay for both diagnostic and therapeutic interventions in gastroenterology. The introduction of AI, […]
The medical community eagerly anticipates Curis’ next steps after their revolutionary drug, Emavusertib (CA-4948), experienced a significant milestone: the lifting of the FDA’s clinical hold. Here’s an in-depth look at what this development means for […]
As Actinium forges ahead with its transformative therapies, including Iomab-B and Actimab-A, its strategic approach extends beyond clinical trials and regulatory milestones. Actinium’s presentation of six abstracts at the Society for Nuclear Medicine and Molecular […]
The pending second Biologics License Application (BsUFA) for AVT02 (Humira biosimilar) by Teva and Alvotech, on June 28th, 2023 (Today), could dramatically alter the dynamics within the Humira biosimilar market. Anticipated approval of AVT02 by […]
What is Prader- Willi Syndrome? How is it manifested? Prader-Willi syndrome is a complex genetic condition that affects many parts of the body. Prader-Willi syndrome in infants is manifested through weak muscle tone (hypotonia), feeding difficulties, […]
As per the Lancet Commission report, the estimated economic impact of mental health disorders will be USD 16 Trillion (direct cost of treatment + lost opportunity costs to society) by 2030, the figures reported prior […]
Acute myeloid leukaemia is a genetically heterogeneous hematologic malignancy in which approximately 8% and 12% of acute myeloid leukemias harbour an IDH1 or IDH2 mutation, respectively. A generally inferior outcome is seen with IDH1 mutations […]
